STML
Stemline Therapeutics, Inc.
STML
STML
Delisted
STML was delisted on the 9th of June, 2020.
61 hedge funds and large institutions have $172M invested in Stemline Therapeutics, Inc. in 2014 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 25 increasing their positions, 15 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
61
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$16.5M | |
| 2 | +$7.56M | |
| 3 | +$3.36M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$3.14M |
| 5 |
PCA
Private Capital Advisors
Darien,
Connecticut
|
+$2.69M |
Top Sellers
| 1 | -$6.85M | |
| 2 | -$6.34M | |
| 3 | -$2.69M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$1.85M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.33M |